Should You Buy Livongo Health Stock Before the Teladoc Acquisition Closes?

The clock is ticking. Livongo Health (NASDAQ: LVGO) and Teladoc Health (NYSE: TDOC) announced on Aug. 5, 2020, that they plan to merge. The deal is expected to close by the end of this year.

Livongo stock has been a huge winner in 2020, with its shares skyrocketing close to 440% year to date. Some investors initially saw the Teladoc transaction as a bad move. But early doubts appear to have given way to optimism that the combination of the two companies could create a digital health juggernaut. Should you buy Livongo Health stock before the Teladoc acquisition closes? 

Image source: Getty Images.

Continue reading

Source Fool.com